ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc.
ME Therapeutics est une société de biotechnologie basée à Vancouver, en phase de démarrage, impliquée dans la découverte et le développement de nouveaux traitements immuno-oncologiques ciblant la suppression immunitaire dans le cancer. Notre objectif principal est de surmonter les effets suppressifs d’une classe importante de cellules immunitaires appelées cellules myéloïdes afin de renforcer l’immunité antitumorale.
ME Therapeutics Holdings Inc. (METX)
ME Therapeutics Holdings Inc. (METX)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
National Bank Financial Inc. | 100 | 10.00 | 12.00 | 500 | RBC Capital Markets |
RBC Capital Markets | 100 | 10.00 | 20.00 | 100 | Anonymous |
RBC Capital Markets | 100 | 7.50 | 0.00 | 0 | |
Anonymous | 200 | 4.00 | 0.00 | 0 | |
Anonymous | 100 | 2.50 | 0.00 | 0 | |
Anonymous | 3,000 | 0.01 | 0.00 | 0 | |
TD Securities Inc. | 300,000 | 0.005 | 0.00 | 0 | |
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
2 | 200 | 10.00 | 12.00 | 500 | 1 |
1 | 100 | 7.50 | 20.00 | 100 | 1 |
1 | 200 | 4.00 | 0.00 | 0 | 0 |
1 | 100 | 2.50 | 0.00 | 0 | 0 |
1 | 3,000 | 0.01 | 0.00 | 0 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
---|---|---|---|---|---|---|
Mar 14, 14:28 | 8.95 | 0.00 | 100 | National Bank Financial Inc. | CIBC World Markets Inc. | CSE |
Mar 13, 19:56 | 8.95 | 0.00 | 200 | RBC Capital Markets | CIBC World Markets Inc. | CSE |
Mar 12, 18:52 | 8.95 | 0.00 | 300 | TD Securities Inc. | CIBC World Markets Inc. | CSE |
Mar 12, 18:19 | 8.95 | 0.00 | 200 | TD Securities Inc. | CIBC World Markets Inc. | CSE |
Mar 12, 17:37 | 8.95 | 0.00 | 100 | TD Securities Inc. | CIBC World Markets Inc. | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Communiqués de presse
Bulletins
2023-1016 - Nouvelles Inscription - ME Therapeutics Holdings Inc. (METX)
le 10 octobre/October 2023
The common shares of ME Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.